Catalent and Blackstone Complete Secondary Offering
03.10.15
This is only gets display when printing
Simpson Thacher represented Catalent, Inc. and Blackstone Healthcare Partners L.L.C., an affiliate of The Blackstone Group, L.P., in connection with a secondary offering of 27,255,000 shares of common stock (including 3,555,000 shares sold pursuant to the underwriters’ full exercise of their option to purchase additional shares) at a public offering price of $29.50, resulting in gross proceeds of approximately $804 million to the selling stockholders. The offering closed on March 9, 2015.
Catalent is the leading global provider of advanced delivery technologies and development solutions for drugs, biologics and consumer health products.
The Simpson Thacher team included Ed Tolley, Xavier Kowalski and Wenli Cai (Capital Markets); Maia Gez and James Rapp (Public Company Advisory Practice); Aimee Adler and Holly Gurian (Executive Compensation and Employee Benefits); Jonathan Karen and Carolyn Houston (Funds); and Jodi Sackel (Tax).